plasmodium
falciparum
malaria
sever
form
malaria
sever
complic
malaria
pigmenthemozoin
hz
associ
sever
anemia
cytokin
dysfunct
immunosuppress
thu
make
interest
target
develop
new
strategi
antimalari
therapi
monocyt
mo
circul
activ
ingest
hz
releas
plasmodium
parasit
secret
proand
antiinflammatori
cytokin
type
repres
two
major
form
mo
macrophag
mq
distinct
phenotyp
oppos
function
imbal
polar
type
report
mani
infecti
diseas
though
associ
hz
immunosuppress
well
document
role
activ
mo
context
phenotyp
remain
address
report
natur
hz
drive
human
mo
toward
phenotyp
evidenc
express
signatur
marker
hzfed
mo
show
elev
transcript
secret
level
express
mannosebind
lectin
receptor
arginas
activ
hz
attenu
hladr
express
nitric
oxid
reactiv
oxygen
speci
product
featur
phenotyp
data
also
implic
involv
mapk
signal
pathway
skew
hzfed
mo
toward
type
suppress
mitogenstimul
lymphocyt
prolifer
importantli
antimalari
drugschloroquin
artemisininparti
revers
activ
hzinduc
mo
toward
phenotyp
consid
limit
current
therapeut
option
malaria
propos
drug
may
reexamin
potenti
immunomodul
candid
adjunct
treatment
malaria
k
e
w
r
artemisinin
chloroquin
hemozoin
monocyt
malaria
u
pp
rti
n
g
n
fo
r
ati
n
addit
support
inform
may
found
onlin
support
inform
section
end
articl
cite
articl
bobad
khandar
av
deval
shastri
p
deshpand
p
hemozoininduc
activ
human
monocyt
toward
phenotyp
partial
revers
antimalari
drugschloroquin
artemisinin
microbiologyopen
http
doi
malaria
one
lead
caus
morbid
affect
around
million
individu
death
endem
region
accord
plasmodium
falciparum
caus
sever
form
malaria
complic
includ
cerebr
malaria
pulmonari
edema
acut
renal
failur
sever
anemia
buffet
et
al
da
medana
turner
mohan
sharma
bollineni
p
falciparum
malaria
frequent
associ
immunosuppress
increas
secondari
infect
hu
ihekwerem
esimon
nwanegbo
orf
cunnington
troyeblomberg
perlmann
immunosuppress
enhanc
parasitemia
reduc
immun
respons
malaria
parasit
protein
pathogen
well
accumul
evid
suggest
combin
parasit
host
factor
involv
pathogenesi
sever
malaria
intraerythrocyt
stage
p
falciparum
parasit
digest
hemoglobin
food
vacuol
result
product
potenti
toxic
heme
metabolit
franci
sullivan
goldberg
parasit
detoxifi
convert
insolubl
crystal
call
malari
pigment
hemozoin
hz
ares
schwarzer
schizogeni
hz
releas
blood
avidli
phagocytos
human
phagocyt
cell
includ
monocyt
mo
shio
kassa
bellemar
olivi
result
hz
uptak
sever
function
mo
repeat
phagocytosi
schwarzer
et
al
bactericid
abil
fiori
et
al
oxid
burst
mhc
class
ii
express
antigen
present
scorza
magez
bri
de
baetseli
matur
dendrit
cell
urban
todryk
sever
affect
mo
activ
respond
ingest
natur
hz
secret
proand
antiinflammatori
cytokin
chemokin
deshpand
shastri
giribaldi
et
al
hz
stimul
product
via
mapk
kinas
human
mo
polimeni
et
al
purifi
hz
isol
parasit
rbc
stimul
signal
induc
product
manner
murin
spleen
dendrit
cell
coban
et
al
murin
mq
cell
line
shown
involv
chemokin
product
induc
hz
jaramillo
godbout
olivi
hzinduc
activ
nodlik
receptor
contain
pyrin
domain
inflammasom
product
mediat
src
kinas
lyn
tyrosin
kinas
syk
pathway
mice
olivi
van
den
ham
shio
kassa
fougeray
shio
et
al
mo
heterogen
innat
immun
cell
play
pivot
role
primari
respons
pathogen
tissu
homeostasi
inflamm
resolut
repair
shi
pamer
mo
highli
plastic
polar
toward
phenotyp
presenc
inflammatori
environ
lp
antiinflammatori
phenotyp
driven
cytokin
phenotyp
associ
antiparasit
tumorresist
capabl
phenotyp
relat
wound
heal
immun
regul
resolut
inflamm
mantovani
et
al
martinez
gordon
sica
mantovani
respons
respect
mantovani
et
al
studi
murray
et
al
describ
differ
type
mq
phenotyp
gener
differ
activ
agent
refer
ig
gc
lp
howev
phenotyp
may
fall
specif
categori
may
show
spectra
relat
particular
phenotyp
phenotyp
display
high
express
mannosebind
receptor
high
arginas
activ
low
nitric
oxid
product
gordon
kobayashi
et
al
mosser
tsuchimoto
et
al
type
mo
divid
subtyp
produc
specif
chemokin
respect
edward
zhang
frauwirth
mosser
mantovani
et
al
sironi
et
al
multipl
signal
pathway
includ
jakstat
pkcerk
involv
mainten
phenotyp
pathway
may
act
individu
combin
drive
mo
toward
polar
gordon
martinez
martinez
gordon
mapk
pathway
mediat
polar
mice
model
jimenezgarcia
herranz
luqu
hortelano
signal
via
mapk
akt
pathway
demonstr
polar
murin
lupu
mous
model
zhang
xu
xiong
recent
studi
enhanc
understand
import
phenotyp
chang
mo
modul
immun
respons
sever
infecti
diseas
buchach
ohradanovarep
stocking
fischer
weber
kobayashi
et
al
nakamura
ito
kobayashi
herndon
suzuki
tsuchimoto
et
al
highlight
potenti
develop
new
therapeut
phenotyp
chang
mo
report
parasit
diseas
leishmaniasi
filariasi
trypanosomiasi
babu
et
al
et
al
accumul
experiment
clinic
data
support
signific
contribut
hz
immunosuppress
role
drive
mo
toward
specif
mo
phenotyp
implic
therein
remain
unravel
present
studi
aim
investig
effect
hz
activ
human
mo
toward
phenotyp
b
examin
signal
pathway
involv
process
c
explor
potenti
antimalari
drugschloroquin
chq
artemisinin
art
revers
hzdriven
activ
mo
steril
tissu
cultur
plastic
purchas
corn
rpmi
media
purchas
sigma
parasit
mo
cultur
ensur
mycoplasma
free
endotoxin
low
inhibitor
sb
parthenolid
par
ly
drug
chq
diphosph
art
purchas
sigma
natur
hz
p
falciparum
isol
describ
previous
slight
modif
barrera
et
al
bujila
et
al
schwarzer
et
al
skorokhod
alessio
mordmul
ares
schwarzer
briefli
p
falciparum
strain
mycoplasma
free
cultur
maintain
candl
jar
trager
jensen
parasit
cultur
oposit
rbc
hematocrit
rpmi
medium
sigma
supplement
mm
hepe
gl
glucos
gl
nahco
albumax
ii
thermo
fisher
scientif
gentamicin
mgml
medium
replenish
everi
h
parasit
cultur
ring
synchron
aqueou
sorbitol
cultur
h
ruptur
matur
schizont
releas
hz
cultur
supernat
contain
hz
care
aspir
collect
centrifug
blackishbrown
hzcontain
pellet
wash
three
time
steril
ice
cold
pb
ph
pigment
isol
differ
batch
parasit
cultur
pool
aliquot
store
pb
total
heme
content
isol
hz
determin
previous
describ
polimeni
et
al
hz
isol
supernat
synchron
parasit
cultur
schizont
ruptur
mostli
devoid
parasit
materi
p
falciparum
dna
detect
natur
hz
concentr
use
experi
agaros
gel
support
inform
figur
studi
use
human
blood
mo
approv
ethic
committe
nation
centr
cell
scienc
pune
india
buffi
coat
obtain
healthi
donor
recruit
blood
collect
governmentrecogn
blood
bank
pune
inform
consent
donor
essenti
discard
buffi
coat
obtain
plasmapheresi
use
peripher
blood
mononuclear
cell
pbmc
isol
buffi
coat
histopaqu
mo
enrich
pbmc
posit
select
use
magnet
bead
mac
miltenyi
biotec
germani
accord
manufactur
instruct
puriti
mo
obtain
viabil
support
inform
figur
adher
mo
phagocytosi
obtain
previous
describ
modif
polimeni
et
al
briefli
ml
seed
per
well
sixwel
tissu
cultur
plate
incub
h
co
rpmi
medium
supplement
mm
hepe
mm
glutamin
mgml
streptomycin
unitsml
penicillin
g
fetal
bovin
serum
sigma
st
loui
mo
cell
wash
rpmi
medium
adher
mo
obtain
incub
overnight
adher
step
appli
mac
phagocytosi
enrich
mo
popul
contain
mo
cultur
medium
replac
fresh
medium
start
experi
phagocytosi
hz
latex
particl
carri
previous
describ
polimeni
et
al
parasit
hz
latex
bead
diamet
dilut
vv
expos
mo
dose
pigment
use
base
hz
amount
detect
p
falciparum
infect
previou
vitro
vivo
studi
deshpand
shastri
jaramillo
et
al
latex
bead
use
phagocyt
control
plate
incub
co
incub
h
allow
phagocytosi
unphagocyt
hz
bead
remov
media
wash
cell
incub
indic
time
interv
cell
signal
experi
mo
pretreat
differ
pharmacolog
pathway
inhibitor
parthenolid
h
prior
phagocytosi
antimalari
drugsart
chq
ad
h
expos
mo
hz
pigment
mo
fed
hz
latex
bead
collect
h
supplement
fb
data
acquir
bd
fac
canto
ii
bd
bioscienc
analyz
use
fac
diva
softwar
flowjo
softwar
bd
bioscienc
paramet
measur
base
ssc
versu
mospecif
gate
cell
mo
fed
hzlatex
collect
h
store
trizol
reagent
life
technolog
inc
gaithersburg
md
rna
isol
total
rna
extract
use
purelink
rna
kit
ambion
usa
follow
manufactur
protocol
trizol
plu
purelink
column
purifi
total
rna
resuspend
rnasefre
water
qualiti
analyz
use
nanodrop
spectrophotomet
ng
rna
revers
transcrib
revers
transcript
system
promega
per
manufactur
instruct
qpcr
analysi
mrna
express
phenotypespecif
marker
gene
hz
latex
fed
mo
perform
use
power
syber
green
thermo
fisher
scientif
genespecif
primer
primer
relat
phenotyp
realtim
pcr
analysi
design
use
ncbi
primer
softwar
custom
synthes
sigma
idt
technolog
oligo
sequenc
list
support
inform
tabl
cycl
paramet
follow
initi
denatur
min
activ
amplitaq
gold
dna
polymeras
follow
total
cycl
compar
threshold
cycl
c
valu
gapdh
use
normal
load
variat
realtim
pcr
extent
mrna
express
given
condit
repres
rel
valu
lower
ddct
estim
differ
condit
control
ddct
valu
fix
specif
pcr
confirm
melt
curv
analysi
realtim
pcr
done
thermocycl
appli
biosystem
appli
biosystem
cytokin
chemokin
level
quantifi
cell
freecultur
supernat
use
elisa
kit
accord
manufactur
instruct
human
elisa
kit
purchas
r
biosystem
purchas
biolegend
purchas
bd
bioscienc
mo
fed
hz
wash
pb
lyse
equal
volum
ripa
buffer
contain
proteas
inhibitor
cocktail
ice
centrifug
min
g
lysat
equal
amount
protein
separ
sdspage
transfer
onto
pvdf
membran
millipor
bedford
usa
block
milk
tb
contain
tween
incub
overnight
primari
antibodi
phosphoakt
total
purchas
abcam
total
santa
cruz
biotechnolog
akt
cell
signal
technolog
santa
cruz
biotechnolog
gapdh
sigma
membran
expos
hrplabel
antirabbit
igg
secondari
antibodi
biorad
h
rt
detect
enhanc
chemiluminesc
detect
system
visual
use
ge
imag
quant
chemiluminesc
system
ge
healthcar
lifesci
adher
mo
prepar
expos
hz
latex
describ
autolog
lymphocyt
previous
col
arginas
activ
determin
colorimetr
assay
sigma
accord
manufactur
instruct
briefli
mo
fed
hz
latex
lyse
mm
trishcl
ph
contain
pepstatin
leupeptin
wv
triton
sampl
centrifug
g
min
remov
insolubl
materi
sampl
incub
substrat
buffer
contain
arginin
buffer
manganes
mn
solut
reaction
occur
h
along
appropri
sampl
blank
urea
standard
separ
well
reaction
termin
ad
urea
reagent
incub
h
absorb
record
nm
arginas
activ
calcul
unitsl
product
cultur
supernat
hz
latex
fed
mo
measur
stabl
end
product
nitrit
use
griess
reagent
briefli
cell
cultur
supernat
ad
plate
triplic
follow
sulphanilamid
dihydrochlorid
plate
incub
dark
min
absorb
nm
measur
micropl
reader
nitrit
concentr
estim
use
sodium
nitrit
standard
curv
media
without
phenol
red
dye
use
assay
reactiv
oxygen
speci
ro
includ
superoxid
hydrogen
peroxid
reactiv
oxygen
intermedi
roi
estim
h
sensit
probe
h
dcfda
thermofish
scientif
flow
cytometri
briefli
hz
latex
fed
mo
incub
h
dcfda
peantihuman
rt
min
dark
pelabel
antihuman
use
gate
mo
fluoresc
dcf
mo
emit
green
fluoresc
proport
intracellular
ro
acquir
bd
fac
canto
ii
data
analyz
use
fac
diva
softwar
valu
express
sem
obtain
three
independ
experi
comparison
group
done
oneway
anova
bonferroni
correct
statist
comparison
made
indic
signific
level
p
p
p
graphpad
softwar
use
statist
analysi
effect
hz
activ
mo
toward
phenotyp
examin
sort
cell
analyz
panel
marker
wellcharacter
antiinflammatori
cytokin
implic
polar
elev
transcript
level
follow
hz
exposur
figur
consist
previou
work
deshpand
shastri
strong
induct
secret
cellular
observ
figur
support
inform
figur
transcript
secret
level
assess
hzfed
mo
treatment
lp
use
posit
control
interestingli
hz
phagocytosi
alter
level
expect
product
increas
mo
expos
lp
support
inform
figur
c
phenotyp
also
induc
microbi
product
tlr
ligand
murray
wynn
murray
et
al
wang
liang
zen
therefor
addit
experi
conduct
examin
tlr
engag
hzdriven
mo
activ
mo
expos
natur
hz
analyz
flow
cytometri
western
blot
express
shz
use
refer
flow
cytometri
analysi
coban
et
al
shown
support
inform
figur
b
natur
hz
effect
express
sug
result
sem
least
three
independ
donor
signific
level
p
p
p
comparison
control
latex
determin
oneway
anova
bonferroni
test
addit
hz
phagocytosi
elev
transcript
level
secret
support
inform
figur
b
amount
hz
rang
significantli
elev
secret
level
surfac
express
mo
support
inform
figur
interestingli
marker
relat
phenotyp
unalt
similar
experiment
condit
support
inform
figur
mo
polar
endow
subtyp
specif
biochem
function
properti
mo
character
elev
product
roi
essenti
clearanc
pathogen
convers
mo
lack
abil
gener
oxid
intermedi
synthesi
ornithin
polyamin
arginas
pathway
found
hzfed
mo
robustli
elev
arginas
activ
figur
significantli
reduc
figur
role
mapk
pathway
implic
synthesi
polar
howev
relev
hzinduc
phenotyp
report
studi
exposur
hz
led
signific
surg
phosphoryla
figur
level
markedli
reduc
hz
presenc
parthenolid
contrast
cytokin
elev
presenc
support
inform
figur
b
act
pathway
along
kinas
may
respons
regul
gharbi
et
al
confirm
role
pathway
use
anoth
inhibitorwortmannin
similar
experi
wortmannin
effect
reduc
level
supernat
mo
fed
hz
signifi
role
pathway
inhibit
phenotyp
support
inform
figur
base
previou
studi
mo
jang
choi
byun
jue
wang
et
al
art
concentr
rang
affect
viabil
mo
assess
cytotox
mtt
assay
support
inform
figur
studi
found
treatment
mo
preexpos
hz
art
result
dramat
reduct
level
figur
figur
hzinduc
activ
inhibit
art
indic
decreas
phosphoryl
increas
mo
support
inform
figur
p
falciparum
infect
manifest
vari
degre
sever
malaria
inclus
uncompl
mild
sever
cerebr
malaria
variabl
suscept
parasit
govern
constant
conflict
immunoprotect
immunopatholog
mantovani
et
al
like
hz
might
facilit
recruit
cell
regulatori
cell
immun
contribut
immunosuppress
noteworthi
context
regulatori
cell
suppress
tcell
respons
malaria
hisaeda
et
al
furthermor
hz
induc
product
human
mo
data
corrobor
report
demonstr
presenc
inflammatori
cytokin
along
high
level
antiinflammatori
plasma
malaria
patient
perera
et
al
weinberg
et
al
function
mo
character
elev
product
roi
essenti
clearanc
pathogen
mantovani
et
al
convers
mo
express
high
arginas
activ
due
product
enzym
convert
arginin
ornithin
urea
caus
deplet
arginin
reduct
biswa
mantovani
oneil
martinez
gordon
malaria
deplet
result
low
bioavail
affect
adher
parasit
endothelium
associ
sever
diseas
high
arginas
activ
invers
relat
diseas
sever
product
recent
report
malaria
weinberg
et
al
context
mo
fed
hz
demonstr
elev
arginas
activ
compar
untreat
latexingest
mo
data
along
find
studi
plasmodium
parasit
olszewski
et
al
lyse
infect
erythrocyt
reiter
et
al
releas
arginas
suggest
cumul
elev
arginas
activ
sourc
might
contribut
activ
recent
studi
report
hzinduc
product
ro
jaramillo
et
al
jaramillo
gowda
radzioch
olivi
mo
contrast
report
found
hz
significantli
reduc
product
ro
level
compar
untreat
latexingest
mo
differ
result
may
attribut
natur
hz
use
earlier
studi
perform
delipid
hz
experi
conduct
natur
hz
addit
mitogenstimul
lymphocyt
prolifer
significantli
suppress
presenc
hzfed
mo
compar
control
latexingest
mo
observ
agreement
studi
malaria
patient
suppress
tand
bcell
function
zander
butler
signal
pathway
mapk
implic
synthesi
saraiva
ogarra
polar
zhang
et
al
studi
hz
f
g
u
r
e
propos
model
hemozoin
hz
induc
monocyt
mo
infect
hz
releas
schizont
ruptur
ingest
circul
mo
blood
activ
mapk
pathway
result
increas
express
marker
arginas
activ
specif
hz
induc
phenotyp
regul
respons
hz
attenu
hladr
express
nitric
oxid
product
reactiv
oxygen
speciesfeatur
phenotyp
antimalari
drugsartemisinin
chloroquineparti
revers
hzinduc
phenotyp
activ
mapk
pathway
pharmacolog
inhibitor
pathway
dramat
downregul
express
secret
thu
overrid
induct
trigger
hz
exposur
line
observ
inhibitor
effect
reduc
hzinduc
phenotyp
biochem
function
properti
find
implic
role
mapk
pathway
rule
possibl
signal
pathway
hzdriven
activ
mo
toward
phenotyp
sinc
hz
induc
specif
phenotyp
subset
drive
mo
toward
type
may
postul
hz
stimul
atyp
activ
mediat
mapk
pathway
next
aim
identifi
strategi
could
aid
revers
effect
hz
drive
mo
phenotyp
regard
conduct
experi
chq
art
three
reason
first
report
inhibit
pathway
crucial
polar
type
second
wide
use
treatment
malaria
third
possess
immunomodulatori
properti
art
report
decreas
level
shakir
hussain
jave
ashraf
riaz
wu
et
al
mapk
wang
et
al
prato
gallo
giribaldi
aldieri
ares
wang
et
al
kim
et
al
pathway
chq
also
demonstr
act
mapk
kono
et
al
weber
chen
levitz
long
liu
wang
zhou
zheng
yang
et
al
pathway
decreas
mononuclear
phagocyt
differ
diseas
jang
et
al
long
et
al
anoth
studi
chq
shown
effect
anticanc
drug
mice
inhibit
tumor
resist
mq
mq
decreas
product
effect
accompani
decreas
myeloidderiv
suppressor
cell
mdsc
treg
increas
cell
tumor
milieu
abil
drug
inhibit
crucial
pathway
product
cytokineschemokin
signatur
type
mo
extend
use
parasit
diseas
rheumat
diseas
cancer
studi
drug
found
effect
reduc
express
phenotyp
markerscytokin
chemokin
surfac
associ
phenotyp
revers
alter
biochem
function
properti
art
revers
arginas
activ
hzfed
mo
find
support
earlier
report
art
significantli
alter
arginas
activ
leishmania
donovaniinfect
mq
though
enhanc
protect
immun
respons
revers
level
sen
ganguli
saha
chatterje
observ
surpris
chq
art
known
antimalari
action
multipl
mode
target
mechan
action
immunomodul
clearli
elucid
phenotyp
previous
relat
abnorm
autophagi
angiogenesi
li
et
al
specul
chq
known
autophagi
inhibitor
may
attenu
hzinduc
mo
activ
inhibit
autophagi
previous
falciparum
malaria
pathogenesi
relat
upregul
angiogen
factor
vegf
along
dysregul
excess
immun
respons
muehlenbach
mutabingwa
edmond
fri
duffi
silver
higgin
mcdonald
kain
antiparasit
action
art
accompani
disrupt
parasit
protein
alter
mitochondri
function
angiogenesi
ak
shakir
et
al
relat
abil
phenotyp
stimul
angiogenesi
art
may
attenu
hzinduc
phenotyp
alter
releas
angiogen
factor
schemat
diagram
figur
summar
hzinduc
alter
marker
pathway
involv
partial
revers
chq
art
human
mo
hz
releas
schizont
ruptur
readili
ingest
circul
mo
blood
activ
mapk
pathway
result
increas
express
marker
drive
mo
toward
like
phenotyp
antimalari
drugsart
chqpartial
revers
process
activ
mo
toward
phenotyp
conclus
find
studi
add
new
dimens
understand
mechan
underli
hzinduc
immunosuppress
demonstr
abil
drive
mo
toward
phenotyp
though
antimalari
resist
pose
major
challeng
discourag
continu
chq
art
propos
drug
may
reexamin
potenti
immunomodul
candid
adjunct
treatment
malaria
thank
dr
sc
mand
director
nation
centr
cell
scienc
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
http
ak
anticanc
effect
antimalari
artemisinin
compound
annal
medic
health
scienc
research
